Regis Vilchez

Title: Regis Vilchez and His Patent on Ornithine Phenylacetate

Introduction

Regis Vilchez is an inventor associated with Chicago, Illinois, and Amalive Limited. His patent work addresses the use of ornithine phenylacetate in treating hyperammonemia, a condition involving elevated ammonia levels in the blood.

Latest Patents

Vilchez is associated with 1 patent: “Dosages and Uses of Ornithine Phenylacetate for Treating Hyperammonemia.” The disclosure describes doses and methods of administering ornithine phenylacetate to treat or ameliorate hyperammonemia in patients with chronic liver disease, such as cirrhosis. Some embodiments also address patients who have hepatic encephalopathy as a complication of liver disease.

Career Highlights

Vilchez’s identified patent work focuses on a therapeutic approach for managing hyperammonemia in people with chronic liver disease. The patent describes dosage and administration methods for ornithine phenylacetate.

Collaborations

The supplied information identifies Xiaofeng Wang Rears and Jack Tseng as Vilchez’s coworkers. It does not specify their roles in the patent or the nature of their collaboration.

Conclusion

Regis Vilchez’s documented patent contribution concerns the dosing and use of ornithine phenylacetate for hyperammonemia, including in patients with chronic liver disease and, in some cases, hepatic encephalopathy.